Skip to content
AdAdvertisement
Value Science Weekly — health economics and market access, in your inbox

Syenza News — health technology assessment, market access and health economics

Syenza's Top Picks

Latest News

prostate cancer screening guideline

Clinical Guidelines And Protocols

ACS Updates Prostate Cancer Screening Guideline for PSA Testing

“The American Cancer Society has updated its prostate cancer screening guideline, with regular PSA testing for average-risk men aged 50 to 69.” #SyenzaNews #ProstateCancer

Syenza TeamRead ›
SADC pharmaceutical pooled procurement

Health Policy

SADC Pharmaceutical Pooled Procurement Charter Signed in Durban

The Charter establishing the SADC Pharmaceuticals Pooled Procurement Services was signed in Durban on 12 November 2026, with Tanzania the first Member State to sign. #SyenzaNews #MarketAccess

Syenza TeamRead ›
Clean laboratory workbench with glass vials and a pharmacist in a white coat

Clinical Practice

Aspen Gets Approval for Generic Semaglutide in Brazil and South Africa

Aspen Pharmacare has received approval for generic semaglutide in Brazil and South Africa, following Canada in July. Launches in all three markets are expected over the coming months. #SyenzaNews #MarketAccess

Syenza TeamRead ›
Villagers in a sunlit European town square beside a market stall of boxes and a balanced pair of brass scales

Drug Pricing

US MFN Drug Pricing: A 25% German Price Rise Would Cut Medicaid Savings by 3.8%

A preprint led by Thomas Hwang models how German price changes affect US Medicaid MFN savings and German statutory health insurance spending.

Syenza TeamRead ›
The EU HTA Regulation offers Latin American agencies lessons on shared clinical evidence, comparators and national decis

Cost Effectiveness Analysis

The EU HTA Regulation: What Latin America Can Learn

A PAHO, RedETSA and HTAi webinar on the EU HTA Regulation: what Latin American agencies can reuse from joint clinical assessments, and which elements may be hard to adapt.

Syenza TeamRead ›
artificial intelligence in medicine regulation

Artificial Intelligence And Machine Learning

Artificial Intelligence in Medicine Regulation: From Concept to Practice

EMA says it is moving artificial intelligence in medicine regulation from concept to practice. Its timeline runs from a 2021 joint workshop to research priorities published in August 2026. #SyenzaNews #MarketAccess #drugregulation

Syenza TeamRead ›
Laboratory microscope and sample tubes on a bench beside a window overlooking a European city

Europe Free account

EMA Draft Guideline on Predictive Biomarker Assays Opens Public Consultation to 31 March 2027

The European Medicines Agency has opened public consultation on its draft guideline on predictive biomarker assays. Comments are accepted from 9 November 2026 until 31 March 2027.

Syenza TeamRead ›
NAION risk with GLP-1 receptor agonists

Clinical Practice

FDA Adds Warning on NAION Risk with GLP-1 Receptor Agonists

FDA is requiring every GLP-1 receptor agonist label to carry a warning on NAION, a rare eye condition that can cause permanent vision loss. #SyenzaNews #drugsafety #GLP1

Syenza TeamRead ›
factor XIa inhibitor for stroke prevention

Cardiovascular And Metabolic Diseases

Factor XIa Inhibitor for Stroke Prevention: FDA Approves Sunharbo

The FDA approved Sunharbo (asundexian), the first factor XIa inhibitor for stroke prevention, for adults after a recent ischemic stroke or high-risk TIA. #SyenzaNews #MarketAccess

Syenza TeamRead ›
Neuquén health technology assessment: Law 3563 sets up a provincial agency whose binding reports guide public coverage.

Cost Effectiveness Analysis

Neuquén Health Technology Assessment Agency: What Law 3563 Sets Up

Law 3563 creates a Neuquén health technology assessment agency. Guadalupe Montero explains how it will weigh safety, benefit, equity and budget impact.

Syenza TeamRead ›

Value Science Weekly

The week in health technology assessment, market access and health economics — what moved, and what it means.

You can unsubscribe at any time. Read our privacy policy.

About this newsletter →

Search Intelligence